Alzheimers & Dementia 2019
World Congress on Alzheimer’s and Dementia is facilitated by EuroSciCon and it is centers around the real issues of Alzheimer's and dementia in individuals. This is of awesome worry as the survival of future age is in question. We welcome Business delegates, Industrial Leaders, neurologist, Consultants, Researchers, Professors, Doctors, Directors, Member of Association and social orders, Pharmaceutical company organization and industrialists and other people who stay dove in learning and routine with regards to neuroscience. The meeting will be a stage to globalize one research, to share logical encounters, to pick up information on new innovations and directions. The gathering will be a stage to globalize one research, to share logical encounters, to pick up learning on new advancements and directions. The gathering is booked on August 06-07, 2019 Paris, France. We welcome supporters and exhibitor to feature your items to our members and influence it to achieve the general population through them. We ask for you to make utilization of this chance to improve the world a place to live in.
What is new?
Alzheimer's and dementia joins overall member workshops, locations and symposia, including a doled out enlistment area, a refreshment break and festivity lunch. Neurologist Neurosurgeons, Psychiatrist, Neuroscientist can join the EuroSciCon as a worldwide part to get refunds on selection. So come and join driving authorities and brought together specialists from August 6-7 at Paris, France to remain mindful of the rapidly stimulating pace of advance that is starting at now influencing the field of Alzheimer’s and dementia.
Who to Attend?
Alzheimer's and dementia is a stand-out exchange to join general perceived scholastics in the field of neuroscience and neurology , Brain researchers , health professionals, general prosperity specialists, scientists, academic analysts, industry examiners, analysts to exchange about best in class research and advances. Purpose of this gathering is engage new musings for treatment that will be beneficial over the scope of Brain disorders. A Unique Opportunity for Advertisers and Sponsors at this International event.
Paris, the world's most popular city destination, has plenty of must-see places but make sure you spend at least a day strolling off the beaten path, as this is the only way to discover the real Paris: a lively cosmopolitan but undeniably French city. The center of Paris is divided in 20 arrondissements with the majority of the world known attractions Eiffel Tower, Champs-Elysées, Louvre, Panthéon, Notre-Dame etc situated in the first 8 arrondissements.
The dining in Paris is iconic: France's notoriety for its cooking goes before it, and whether you look for a comfortable neighborhood bistro or a triple-Michelin-featured sanctuary to gastronomy, you'll discover each foundation prides itself on lovely planning and introduction of quality deliver, constantly presented with wine. Tempting patisseries, boulangeries (pastry kitchens), fromageries (cheddar shops) and swarmed, beautiful road markets are ideal for an outing to take to the city's parks and gardens. A large group of culinary courses – from home kitchens through to the world's most lofty cookery schools – offers direction for all calendars, capacities and spending plans. Paris remains at the forefront of international trends, and browsing emerging and established designer boutiques and flagship haute couture houses is a quintessential part of any visit.
SESSIONS AND TRACKS
ALZHEIMERS DISEASE AND DEMENTIA
Alzheimer's is the most broadly perceived kind of dementia, a general term for memory adversity and other subjective limits adequately honest to goodness to interfere with step by step life. Alzheimer's contamination speaks to 60 to 80 percent of dementia cases. The best-known danger factor is extending age, and most of the people with Alzheimer's are 65 and more prepared. Be that as it may, Alzheimer's isn't just an infection of development. In any case, Alzheimer's isn't just a contamination of rank.
• Increasing age
• Multi-infarct dementia
BEHAVIORAL PROBLEMS IN ALZHEIMERS DISEASE
At the point when Alzheimer's disturbs memory, dialect, considering and thinking, these impacts are alluded to as "intellectual manifestations" of the infection. The expression "behavioral and mental manifestations" depicts a vast gathering of extra indications that jump out, at any rate, some degree in many, however in no way, shape or form all, people. In the beginning periods of the illness, individuals may encounter identity changes, for example, fractiousness, tension or wretchedness. In later stages, different side effects may happen, including rest aggravations; tumult (physical or verbal upheavals, general enthusiastic trouble, eagerness, pacing, destroying paper or tissues, hollering); fancies (solidly held confidence in things that are not genuine); or fantasies (seeing, hearing or feeling things that are not there).
- Plaques and tangles in the mind
- Frequent failures of memory, particularly of late recollections
- The difficulty with willful developments, physical coordination
- Withdrawing from social contact
The nerve cell hurt caused by frontotemporal dementia prompts loss of limit in these mind regions, which smoothly cause debilitating in direct and character, tongue disrupting impacts or modifications in muscle or motor limits. There are different unmistakable disorders that reason frontotemporal degenerations. The two most obvious are 1) a social occasion of cerebrum issue including the protein tau and 2) a get-together of mind issue including the protein Called TDP4. For reasons that are not yet known, these two social occasions have a slant for the frontal and transient folds that reason dementia.
• Muscle inadequacy
Vascular dementia, otherwise called multi-infarct dementia (MID) and vascular intellectual weakness (VCI), is dementia caused by issues in the supply of blood to the mind, normally a progression of minor strokes, prompting compounding psychological decrease that happens well ordered. The term alludes to a disorder comprising of a perplexing communication of cerebrovascular sickness and hazard factors that prompt changes in the cerebrum structures because of strokes and sores and coming about changes incomprehension. The fleeting connection between a stroke and subjective deficiencies is expected to make the determination.
• Trouble talking or understanding discourse
Mixed dementia is a condition in which variations from the normal for in excess of one sort of dementia happen at the same time. Doctors may likewise call mixed "Dementia multifactorial." In the most widely recognized type of mixed dementia, the strange protein stores related to Alzheimer's illness exist together with vein issues connected to vascular dementia. Alzheimer's cerebrum changes additionally frequently coincide with Lewy bodies. Now and again, a man may have cerebrum changes connected to each of the three conditions Alzheimer's malady, vascular dementia, and dementia with Lewy bodies.
• Protein statement
• Depends on the sorts of cerebrum changes included and the mind districts influenced
• The abnormality was already undetected blood clumps or other proof of vascular sickness.
• Mixed dementia may greatly affect the mind than one sort alone
LEWY BODY DEMENTIA
Lewy body dementia, otherwise called dementia with Lewy bodies, is the second most basic sort of dynamic dementia after Alzheimer's infection dementia. Protein stores, called Lewy bodies, create in nerve cells in the mind districts associated with considering, memory and development (engine control). Lewy body dementia causes a dynamic decrease in mental capacities. Individuals with Lewy body dementia may encounter visual mind flights and changes in sharpness and consideration. Different impacts incorporate Parkinson's malady like indications, for example, inflexible muscles, moderate development, and tremors.
• Alpha-synuclein protein stores
• Visual fantasies
• Identifiable prodromal stage in Lewy body dementia
ALZHEIMERS DISEASE PATHOGENESIS AND MECHANISM
The trademark highlights of Alzheimer's sickness (AD) are the presence of extracellular amyloid-beta (Aβ) plaques and neurofibrillary tangles in the intracellular condition, neuronal demise and the loss of neurotransmitters, all of which add to a subjective decrease in a dynamic way. Various theories have been progressed to clarify AD. Unusual tau phosphorylation may add to the arrangement of strange neurofibrillary structures. A wide range of structures are powerless to AD, including the reticular arrangement, the cores in the mind stem (e.g., raphe core), thalamus, hypothalamus, locus ceruleus, amygdala, substantia nigra, striatum, and claustrum. Excitotoxicity comes about because of persistent, low-level initiation of N-methyl-D-aspartate (NMDA) receptors.
• Premature synaptotoxicity, changes in neurotransmitter articulation
• Amassing of amyloid β-protein stores
CLINICAL TRIALS ON ALZHEIMER'S DISEASE
NeuroTrials Research is driving a 20-month, fake treatment controlled research consider assessing an investigational calm for Alzheimer's infirmity. Study-related exams and concentrate quiet are given at no cost. Qualified people and guardians will be adjusted for time and travel.
• Clinical Studies Of Alzheimer's
• Clinical trial outline and frameworks
ALZHEIMERS DISEASE CAUSES
In Alzheimer's malady, cerebrum cells begin to break down. The body endeavors to stop this procedure by creating a protein called amyloid. In any case, amyloid stores develop in the cerebrum, prompting further crumbling. These stores of amyloid are alluded to as "plaques" and make the cerebrum cells shrink up and frame "tangles", which thus prompt changes in the mind structure and make the mind cells kick the bucket. The arrangement of plaques and tangles likewise keeps the creation of some essential cerebrum chemicals, called neurotransmitters (eg: acetylcholine, which is imperative in memory work). After some time the loss of cerebrum cells makes the mind recoil.
• Distrust in others
• Changes in resting propensities
• Loss of restraints
• Delusions, for example, thinking something has been stolen
ALZHEIMERS CARE PRACTICE
Alzheimer’s disease causes brain cells to die, so the brain works less well over time. This changes how a person acts. This article has suggestions that may help you understand and cope with changes in personality and behavior in a person with Alzheimer’s disease.
Common personality and behavior changes you may see include:
- Getting upset, worried, and angry more easily
- Acting depressed or not interested in things
- Hiding things or believing other people are hiding things
- Imagining things that aren’t there
- Wandering away from home
- Pacing a lot
- Showing unusual sexual behavior
- Hitting you or other people
- Misunderstanding what he or she sees or hears
DRUG DEVELOPMENT IN DEMENTIA
Most medication medicines as of now being developed have focused on the pathology of Alzheimer's ailment, the most widely recognized type of dementia, which represents around 60 to 70% of all cases. Finding a fruitful treatment for Alzheimer's faces two noteworthy obstacles: the first being despite everything we don't know enough about the malady's hidden science. For instance, we don't realize what precisely controls the poisonous develop of amyloid-β plaques and tau tangles in the mind that are found in Alzheimer's patients, which particular sorts of these are lethal, or why the malady advances at various rates in various individuals. It doesn't help that side effects of Alzheimer's grow bit by bit and gradually and a conclusion may just be made a long time after the cerebrum has begun to experience neurodegenerative changes. To boot, it's normal for Alzheimer's to be available and additionally different types of dementia.
MANAGEMENT OF DEMENTIA
Having control of our life is something we as a whole esteem, however, every now and again underestimate. Deciding – on where we live, what we do, where we go and how we spend our cash – are critical to every one of us. Individuals with dementia additionally need to be responsible for their lives. Early analysis and dealing with the indications viably make this conceivable in most by far of cases.
• Cognitive and neuropsychological tests
• Neurological assessment
• CT or MRI, PET outputs.
• Vitamin B-12 lack or an underactive thyroid organ
NURSING CARE IN DEMENTIA
The danger of creating dementia increments with age, as does the danger of growing long-haul conditions, for example, joint inflammation, diabetes and cerebrovascular or respiratory issues. 'Seniority' happens prior to individuals with learning incapacities, and this gathering is especially defenseless against intellectual impedance. Individuals with dementia in this manner regularly have coinciding issues or comorbidities. Whenever 25% of patients in a general doctor's facility may have dementia and this gathering is at higher danger of readmission and passing than different patients conceded with similar conditions – this implies the distinguishing proof and care of individuals with dementia is an urgent obligation regarding medical caretakers.
• Encouraging socialization.
• Encouraging mental incitement.
• Encouraging important action and subjective incitement.
• Encouraging individuals with dementia to look after freedom.
• Providing support for families and carers.
RECENT ADVANCEMENT IN DEMENTIA
Mental treatments for dementia are beginning to increase some energy. Enhanced clinical appraisal in beginning times of Alzheimer's infection and different types of dementia, expanded subjective incitement of the elderly, and the medicine of medications to moderate intellectual decrease have brought about expanded identification in the beginning periods. Despite the fact that the feelings of the medicinal group are as yet uncertain to help subjective treatments in dementia patients, late worldwide investigations have begun to make idealism.
• Cholinergic receptor and forebrain volumetric investigations
NEUROIMAGING IN DEMENTIA AND ALZHEIMERS
The piece of imaging in dementia has usually been composed at choice out treatable and reversible etiologies and not to use imaging to better grasp the pathophysiology of the assorted dementias. Unmistakable cerebrum imaging methods allow the examination of the structure, natural science, metabolic state, and handy breaking point of the brain. Most of the major neurodegenerative issue have decently specific imaging revelations that can be recognized. New imaging frameworks pass on the desire of transforming the finding of neurodegenerative affliction keeping in mind the end goal to get an aggregate sub-nuclear, helper, and metabolic depiction, which could be used to upgrade investigation and to organize each patient and take after contamination development and response to treatment. Assistant and down to earth imaging modalities add to the investigation and cognizance of the unmistakable dementias.
• MR spectroscopy
• Positron release tomography
BIOMARKERS FOR DEMENTIA
Biomarkers are measures of what is going on inside the living body, appeared by the aftereffects of the research center and imaging tests. Biomarkers can enable specialists and researchers to analyze maladies and wellbeing conditions, discover wellbeing dangers in a man, screen reactions to treatment, and perceive how a man's illness or wellbeing condition changes after some time. For instance, an expanded level of cholesterol in the blood is a biomarker for the heart-assault chance. Numerous sorts of biomarker tests are utilized to investigating on Alzheimer's infection and related dementias. Changes in the brains of individuals with these clusters may start numerous prior years’ memory misfortune or different side effects show up. Specialists utilize biomarkers to help recognize these mind changes in individuals, who might have evident changes in memory or consider. Finding these progressions ahead of schedule in the sickness procedure distinguishes individuals who are at the most serious danger of Alzheimer's or another dementia and may help figure out which individuals may profit most from a specific treatment.
- Cerebrospinal Fluid Biomarkers
- Beta-amyloid 42 might be estimated with touchy blood tests.
- Genetic testing for APOE ε4, the principle hereditary hazard factor for late-beginning Alzheimer's infection
ANIMAL MODELS FOR DEMENTIA RESEARCH
Alzheimer's malady (AD) is the most well-known reason for the dynamic decay of intellectual capacity in matured people and is portrayed by the nearness of various feeble plaques and neurofibrillary tangles joined by neuronal misfortune. A few, however not all, of the neuropathological adjustments and subjective hindrance in the AD can be duplicated hereditarily and pharmacologically in creatures. It ought to be conceivable to find novel medications that moderate the advance or reduce the clinical manifestations of the AD by utilizing these creature models. We audit the current advance in the improvement of creature models of the AD and talk about how to utilize these model creatures to assess novel against dementia drugs.
• Animal models of human psychological maturing
• Protein-protein communications
• Pre-clinical testing and clinical interpretation
THERAPEUTIC APPROACH TOWARDS DEMENTIA
Therapeutic ways to deal with treat the intellectual impedance in dementia and to treat moderate decrease are advancing into clinical practice. Cholinergic operators are right now the most encouraging treatment, and a few cholinesterase inhibitors will soon be accessible for remedy. As doctors take in more about dosing, symptoms, and components of activity, they can recommend these medications all the more proficiently. Confirmation proposes that specific patients with dementia might be especially receptive to such mediation, and different prescriptions may upgrade reaction. Current exploratory ways to deal with abating the rate of intellectual decay incorporate the utilization of cancer prevention agents, monoamine oxidase-B inhibitors, cholinesterase inhibitors, and calming operators. Psychosocial mediations seem to help defer standardization. Medications that enhance insight additionally may influence behavioral side effects and serious dementia and also non-Alzheimer dementia.
• Novel hostile to amnesic medications got from manufactured science or those got from customary homegrown sources.
• Cholinesterase inhibitors
• Monoamine oxidase-B inhibitors
RISK FACTORS AND PREVENTION
Hazard factors are attributes of the individual, a way of life, condition, and hereditary foundation that add to the probability of getting a sickness. Hazard factors without anyone else are not reasons for a sickness. Hazard factors speak to an expanded possibility, however not a conviction, that Alzheimer's infection will create. Additionally, having next to zero presentation on known hazard factors do not really shield a man from building up the infection
Some hazard factors are modifiable, which implies they can be changed (e.g., smoking, hypertension); other hazard factors are non-modifiable, which implies they can't be changed (e.g., age, hereditary cosmetics).
• Keep physically dynamic
• Eat a sound adjusted eating regimen
• Keep your liquor inside suggested limits
PROGNOSIS OF DEMENTIA
In applying the examination's outcomes to patients, nonetheless, we should perceive an unobtrusive yet clinically imperative qualification. The examination looks at survival after a finding of Alzheimer infection, which isn't really the same as survival after the beginning of the sickness. Since subjective decrease is regularly treacherous, distinguishing the exact time when a patient initially meets symptomatic criteria for dementia is troublesome without visit psychological testing. This entangles the translation of such hazard factors as walk unsettling influence or the seriousness of subjective disability. It isn't certain whether patients with these hazard factors have more awful survival since they have more forceful types of dementia or on the grounds that these hazard factors can note patients whose dementia was analyzed at a later point in its characteristic history.
• Increased predominance in patients with dementia with Lewy bodies.
INSULIN RESISTANCE ON DEVELOPMENT OF DEMENTIA
Persuading preclinical and clinical supports a pathophysiological relationship between Alzheimer's affliction (AD) and diabetes. Adjusted assimilation, disturbance, and insulin protection are key psychotic parts of the two diseases. For quite a while, it was generally viewed as that the cerebrum was savage to insulin; in any case it is directly recognized that this hormone has central neuromodulatory limits, consolidating parts in learning and memory, that are incapacitated in AD. Nevertheless, so far, the sub-nuclear segments speaking to cerebrum insulin protection in AD have remained precarious. Here, we overview late proof that uncovers knowledge into how cerebrum insulin brokenness is begun at a nuclear level and why atypical insulin hailing ends up at ground zero in synaptic dissatisfaction and memory rot. We in like manner look at the telephone commence essential the beneficial effects of actuation of cerebrum insulin motioning on observation. Divulgences sketched out here give pathophysiological establishment to unmistakable evidence of novel sub-nuclear targets and for development of choice accommodating techniques in the AD.
• Insulin and Cognition
• Insulin Resistance
CURRENT RESEARCH AND STRATEGIES
Alzheimer's sickness (AD) as of now introduces one of the greatest social insurance issues in the created nations. There is no viable treatment equipped for backing off illness movement. As of late the fundamental focal point of research on novel pharmacotherapies depended on the amyloid genic theory of AD, which sets that the beta-amyloid (Aβ) peptide is mainly in charge of subjective hindrance and neuronal demise. The objective of such medicines is (a) to lessen Aβ creation through the hindrance of β and γsecretase compounds and (b) to advance disintegration of existing cerebral Aβ plaques. Be that as it may, this approach has turned out to be just humbly viable. Late examinations propose an elective technique fixated on the hindrance of the downstream Aβ flagging, especially at the neural connection. Aβ oligomers may cause atypical N-methyl-D-aspartate receptor (NMDAR) enactment postsynaptically by framing edifices with the phone surface prion protein (PrPC). PrPC is enhanced at the neuronal postsynaptic thickness, where it communicates with Fyn tyrosine kinase.
• Aβ flagging
• N-methyl-D-aspartate receptor (NMDAR) enactment
• Inhibition of β and γsecretase chemicals
• Reduce Aβ generation
NEURODEGENERATION AND GENETICS
Quality deformities assume a noteworthy part in the pathogenesis of degenerative issue of the sensory system. Truth be told, it has been the very learning picked up from hereditary examinations that have permitted the illustration of the sub-atomic components hidden the etiology and pathogenesis of numerous neurodegenerative issue. In this audit, we talk about the ebb and flow status of hereditary the study of disease transmission of the most well-known neurodegenerative maladies: Alzheimer sickness, Parkinson ailment, Lewy body dementia, frontotemporal dementia, amyotrophic sidelong sclerosis, Huntington infection, and prion illnesses, with a specific spotlight on similitudes and contrasts among these disorders.
• Genetic cerebrum issue incorporate leukodystrophies,
• Tay-Sachs ailment,
• Wilson ailment,
• Huntington's ailment
AMYLOID PROTEIN IN DEMENTIA
Single plaques (SP) and neurofibrillary tangles (NFT) are the major histopathological changes that happen in Alzheimer's sickness (AD). How these two distinct kinds of sores are identified with each other and to the dementia of AD is obscure. Late investigations prompt dumbfounding conclusions: NFT and neuronal adjustments, for example, neurotransmitter misfortunes are considerably more firmly identified with the manifestations of dementia than are SP. In any case, changes in the beta-amyloid protein of SP have been found in a few patients with the familial AD, recommending that an anomaly in amyloid causes the improvement of SP, NFT and AD dementia. Examination of transgenic creatures that deliver amyloid antecedent protein (APP), or adjusted types of APP, may prompt the advancement of a creature model of the AD, and at last to answers that connection amyloid generation to neuronal changes, and intellectual weaknesses.
• Amyloid Plaques gathering between nerve cells (neurons)
• Neurofibrillary Tangles are insoluble curved strands found inside the mind's cells
• In vertebrates the amyloid forerunner protein-like in Drosophila.
• Function as a receptor for kinesin-1-interceded axonal transport
Neurosurgery restorative distinguishing strength stressed over the investigation and medicinal method on the cerebrum, spinal string, and tangible framework. Neurological edges join the focal degrees of advance of neurosurgery getting to be compelling after the fundamentally made mechanical gathering. These consolidate advanced neurosurgical devices or instruments; intertwine scratches, curettes, dissectors, distractors, lifts, control contraptions, gets, suction tubes and robots.
•Advanced Operative Techniques in Neurosurgery
MARKETING STRATEGIES OF DEMENTIA
The Alzheimer's Association is the general pioneer in Alzheimer's headway, research, and support. To improve and brace this master position, and extend the centrality, expansiveness, and pace of the Alzheimer's progression, we have made arrangements to accomplish more. The establishment of the FY15 - FY18 Strategic Plan is a remarkable, 10-year vision for the Alzheimer's disease change, going past what the Association can accomplish with no other individual. This vision and this first of three key intends to achieve it, sets clear vital turning points for the Alzheimer's Association to fortify advance. While it won't be conceivable to accomplish this vision alone, the Association has a magnificent part to play in changing the course of Alzheimer's and supporting a gigantic number of individuals living with the disease.
Entrepreneurs Investment Meet
Recommended Euroscicon conferences: Feb 27-28, 2019 Czech Republic | Euro Gastro 2019, March 11-12, 2019 Netherlands | Dental & Dental Hygiene, March 25-26, 2019 Hungary | Data Analytics , April 08-09, 2019 France | Dermatology 2018, April 18-19, 2019 France | Microbiology and Virology, April 22-23, 2019 Greece | Infectious Diseases & Std-Aids 2019 April 15-16, 2019 France | Quantum & Plasma physics , May 09-10, 2019 Sweden | Euro Optics , May 09-11, 2019 Sweden | Advance Nursing Practice, May 23-24, 2019 Sweden | Psychiatry & Psychology , April 11-12, 2019 France | Renewable and Green Energy, March 21-22, 2019 Netherlands| Nano 2019, Oct 07-09, 2019, Japan | Advanced Energy Materials, Oct 07-09, 2019 Japan | Materials Science & Engineering, June 04-06, 2019 France | Nursing Diagnosis, July 25-26, 2019 Luxembourg |Nursing & Midwifery, May 23-24, 2019 Sweden | Nuclear Medicine & Radiation Therapy, June 10-12, 2019 Netherlands
University of Cambridge |University College London |Max Planck Society |University of Oxford | Maastricht University |Vrije University Amsterdam |University of St Andrews|University of Edinburgh |Imperial College London |University of Bonn |University of Amsterdam |University of Bristol |University Pompeu Fabra |University of Trieste|Karolinska Institute |University of Gothenburg|University of Milan |VU University Amsterdam |
Colorado State University |Washington State University |University of Illinois at Chicago|Stony Brook University |University of Idaho|Loyola University Chicago |California State University |Jefferson (Philadelphia University an |College of Staten Island |College of Staten Island |University of Maryland | University of Houston Clear Lak |University at Buffalo|Albany Medical College |University of Rhode Island | University of Rhode Island|Metropolitan State University |Wright State University | Northwestern University |The City University of New York |Kent State University|Michigan State University | Texas Tech University Health Sc |Boston University |Stony Brook Medicine | Queens College | Texas A&M University |Central Michigan University|University of Wisconsin Madis |University of Minnesota Twin Cit |Rutgers University|Brigham Young University | Pennsylvania State University |University of Southern California|Colorado Mesa University | University of Kansas |California State University North|Brandeis University |State University of New York | George Mason University | University of Texas at Dallas |Southern Illinois University|The University of Montana |
|The University of Western Austra | La Trobe University | The University of National University of Singapore (NUS) | University of Hong Kong | Nanyang Technological University | Hong Kong University of Science and Technology | Tsinghua University | KAIST - Korea Advanced Institute of Science & Technology | City University of Hong Kong | The Chinese University of Hong Kong (CUHK) | Peking University |Seoul National University Western Australia |Macquarie University |Monash University |The University of Western Austra|Australian National University |NATIONAL RESEARCH LOBACHEVSKY STATE | UNIVERSITY OF NIZHNI NOVGOROD |Nanjing University Nationa | Yang Ming University|Universiti Putra Malaysia (UPM) |Beijing Institute of Technology |Kyoto University|Osaka University |University of Tsukuba |
University of Cambridge |Max Planck Society | University of Oxford |University of Edinburgh |Imperial College London |University of Bonn |University of Amsterdam |University of Bristol |Karolinska Institute |University of Gothenburg |University of Milan |VU University Amsterdam |Anadolu Medical Center |Vithas Xanit International Hospital |Hospital Ruber International |Centro Médico Teknon |HM Hospitales |Heidelberg University Hospital |Kardiolita Private Hospital
Johns Hopkins Hospital | Massachusetts General Hospital | New York-Presbyterian Hospital | Barnes-Jewish Hospital | University of Michigan Hospitals and Health Centers | Northwestern Memorial Hospital | Stanford Health Care-Stanford Hospital | Cedars-Sinai Medical Center | DMC Harper University Hospital | Mayo Clinic | New York-Presbyterian University Hospital of Columbia and Cornell | Johns Hopkins Hospital | Massachusetts General Hospital | University of California–San Francisco Medical Center | Cleveland Clinic | University of California–Los Angeles Medical Center | New York University Langone Medical Center | Hospitals of the University of Pennsylvania–Penn Presbyterian| Northwestern Memorial Hospital |
Fortis Malar Hospital | Chiangmai Ram Hospital | Columbia Asia Hospitals | KPJ Tawakkal Specialist Hospital | Raffles Hospital| Bangkok Hospital Pattaya | KPJ Ampang Puteri Specialist Hospital | Mount Elizabeth Hospital | Yanhee Hospital | Herzliya Medical Center | KPJ Damansara Specialist Hospital | Narayana Hrudayalaya Health City | Columbia Asia Hospital - Palam Vihar | BNH Hospital | Sheba Medical Center | Apollo Hospital Chennai | St. Luke's Medical Center | Chaophya Hospital | Sevenhills Hospital | Fortis Mohali Hospital | Gleneagles Medical Centre Penang | Bumrungrad Hospital
Journal of Addiction Research & Therapy|Journal of Alzheimers Disease & Parkinsonism |International Journal of Emergency Mental Health and Human Resilience |Autism-Open Access |Journal of Psychiatry |Journal of Novel Physiotherapies|Neuropsychiatry |Journal of Psychology & Psychotherapy |Journal of Neurology & Neurophysiology |Journal of Neurology and Neuroscience |Journal of Depression and Anxiety |Journal of Neuroinfectious Diseases|Journal of Gerontology & Geriatric Research|Journal of Pain & Relief |Journal of Clinical Case Reports |Journal of Spine & Neurosurgery |Journal of Neurological Disorders |Journal of Multiple Sclerosis|International Journal of Neurorehabilitation|Journal of Trauma & Treatment |Journal of Traumatic Stress Disorders & Treatment|Journal of Addictive Behaviors, Therapy & Rehabilitation |Journal of Sleep Disorders : Treatment and Care |Journal of Spine